Literature DB >> 10328251

Longitudinal cognitive and motor changes among presymptomatic Huntington disease gene carriers.

S C Kirkwood1, E Siemers, J C Stout, M E Hodes, P M Conneally, J C Christian, T Foroud.   

Abstract

OBJECTIVE: To determine whether longitudinal changes in cognitive and motor function can be detected among clinically presymptomatic individuals carrying the Huntington disease (HD) allele.
DESIGN: A longitudinal, case-control, double-blind study comparing presymptomatic gene carriers and non-gene carriers at risk for HD examined an average of 3.7 years apart.
SETTING: The Department of Medical and Molecular Genetics at a general clinic research center in Indianapolis, Ind. PARTICIPANTS: A sample of 43 at-risk individuals consisting of presymptomatic gene carriers (n = 12) and non-gene carriers (n = 31). MEASURES: Huntington disease gene status was determined by molecular testing of the HD gene. Subscales from the Wechsler Adult Intelligence Scale-Revised and a quantified neurologic rating scale were administered.
RESULTS: Scores on the digit symbol subscale of the Wechsler Adult Intelligence Scale-Revised (P<.05) and 2 neurologic variables-optokinetic nystagmus (P<.01) and rapid alternating movements (P<.005)-declined more rapidly among presymptomatic gene carriers than among non-gene carriers. At follow-up examination, compared with nongene carriers, presymptomatic gene carriers had significantly lower scores on the digit symbol subscale (P = .02) and for 4 neurologic variables-rapid alternating movements (P<.005), optokinetic nystagmus (P<.001), overall ocular movements (P<.02), and chorea of the trunk (P<.02).
CONCLUSIONS: Psychomotor speed, optokinetic nystagmus, and rapid alternating movements demonstrated significant decline early in the pathological process of HD. These results suggest that subtle worsening of psychomotor, oculomotor, and motor functions occurs before the onset of signs sufficient to make a clinical diagnosis in individuals who have inherited the HD allele.

Entities:  

Mesh:

Year:  1999        PMID: 10328251     DOI: 10.1001/archneur.56.5.563

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  34 in total

Review 1.  Methodology in longitudinal studies on psychological effects of predictive DNA testing: a review.

Authors:  R Timman; T Stijnen; A Tibben
Journal:  J Med Genet       Date:  2004-07       Impact factor: 6.318

2.  "Frontal" behaviors before the diagnosis of Huntington's disease and their relationship to markers of disease progression: evidence of early lack of awareness.

Authors:  Kevin Duff; Jane S Paulsen; Leigh J Beglinger; Douglas R Langbehn; Chiachi Wang; Julie C Stout; Christopher A Ross; Elizabeth Aylward; Noelle E Carlozzi; Sarah Queller
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2010       Impact factor: 2.198

3.  Huntington's disease: changes in saccades and hand-tapping over 3 years.

Authors:  Chrystalina A Antoniades; Zheyu Xu; Sarah L Mason; R H S Carpenter; Roger A Barker
Journal:  J Neurol       Date:  2010-06-29       Impact factor: 4.849

4.  Visual scanning and cognitive performance in prediagnostic and early-stage Huntington's disease.

Authors:  Tanya Blekher; Marjorie R Weaver; Jeanine Marshall; Siu Hui; Jacqueline Gray Jackson; Julie C Stout; Xabier Beristain; Joanne Wojcieszek; Robert D Yee; Tatiana M Foroud
Journal:  Mov Disord       Date:  2009-03-15       Impact factor: 10.338

5.  Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington's disease mice.

Authors:  M A Hickey; A Kosmalska; J Enayati; R Cohen; S Zeitlin; M S Levine; M-F Chesselet
Journal:  Neuroscience       Date:  2008-08-27       Impact factor: 3.590

6.  Movement sequencing in Huntington disease.

Authors:  Nellie Georgiou-Karistianis; Jeffrey D Long; Spencer G Lourens; Julie C Stout; James A Mills; Jane S Paulsen
Journal:  World J Biol Psychiatry       Date:  2014-03-28       Impact factor: 4.132

7.  Cognitive changes in patients with Huntington's disease (HD) and asymptomatic carriers of the HD mutation--a longitudinal follow-up study.

Authors:  Jurgen Lemiere; Marleen Decruyenaere; Gery Evers-Kiebooms; Erik Vandenbussche; Rene Dom
Journal:  J Neurol       Date:  2004-08       Impact factor: 4.849

8.  Ten-year rate of longitudinal change in neurocognitive and motor function in prediagnosis Huntington disease.

Authors:  Andrea C Solomon; Julie C Stout; Marjorie Weaver; Sarah Queller; Allison Tomusk; Kathryn Burr Whitlock; Siu L Hui; Jeanine Marshall; Jacqueline Gray Jackson; Eric R Siemers; Xabier Beristain; Joanne Wojcieszek; Tatiana Foroud
Journal:  Mov Disord       Date:  2008-10-15       Impact factor: 10.338

9.  Brain activation and functional connectivity in premanifest Huntington's disease during states of intrinsic and phasic alertness.

Authors:  Robert Christian Wolf; Georg Grön; Fabio Sambataro; Nenad Vasic; Nadine Donata Wolf; Philipp Arthur Thomann; Carsten Saft; G Bernhard Landwehrmeyer; Michael Orth
Journal:  Hum Brain Mapp       Date:  2011-08-25       Impact factor: 5.038

10.  Use of the frontal assessment battery in evaluating executive dysfunction in patients with Huntington's disease.

Authors:  Guilherme Riccioppo Rodrigues; Carolina Pinto Souza; Roberto Satler Cetlin; Daniel Sabino de Oliveira; Marcio Pena-Pereira; Liliana Tiemi Ujikawa; Wilson Marques; Vitor Tumas
Journal:  J Neurol       Date:  2009-06-18       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.